blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3666886

EP3666886 - THERAPEUTIC PEPTIDES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.05.2021
Database last updated on 16.09.2024
FormerThe application has been published
Status updated on  15.05.2020
Most recent event   Tooltip21.05.2021Application deemed to be withdrawnpublished on 23.06.2021  [2021/25]
Applicant(s)For all designated states
Dana-Farber Cancer Institute, Inc.
450 Brookline Avenue
Boston, MA 02115-5450 / US
[2020/25]
Inventor(s)01 / WUCHERPFENNIG, Kai W.
67 Highland Road
Brookline, MA Massachusetts 02445 / US
02 / DRANOFF, Glenn
150 Concord Road
Sudbury, MA Massachusetts 01776 / US
03 / HODI, F., Stephen
15 Vaillencourt Drive
Framingham, MA Massachusetts 02115 / US
04 / FRANZ, Bettina
9 Sherman House
Rustat Avenue
Cambridge, MA CB1 3RF
GB / GB
05 / MAY, Kenneth, F.
3141 madrona Lane
Bozeman, MT 59715 / US
06 / HARVEY, Christopher
8 Conway Street
Boston, MA Massachusetts 02131 / US
 [2020/25]
Representative(s)Ter Meer Steinmeister & Partner
Patentanwälte mbB
Nymphenburger Straße 4
80335 München / DE
[2020/25]
Application number, filing date19207376.514.03.2014
[2020/25]
Priority number, dateUS201361792034P15.03.2013         Original published format: US 201361792034 P
US201361913198P06.12.2013         Original published format: US 201361913198 P
[2020/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3666886
Date:17.06.2020
Language:EN
[2020/25]
Search report(s)(Supplementary) European search report - dispatched on:EP20.04.2020
ClassificationIPC:C12N5/0783, A61K39/395, A61K35/14, C07K16/28, A61K35/17, A61K38/12, A61K38/15, A61P35/00, A61K45/06, // A61K39/00
[2020/25]
CPC:
C07K16/2833 (EP,US); A61K38/12 (EP,US); A61K38/15 (EP,US);
A61K39/39558 (EP,US); A61K39/4613 (EP); A61K39/4644 (EP);
A61K45/06 (EP,US); A61N5/10 (US); A61P35/00 (EP);
C07K16/30 (US); C07K16/3015 (US); C07K16/3023 (US);
C07K16/3053 (US); C07K16/3061 (US); C07K16/3069 (US);
A61K2039/505 (EP,US); A61K35/17 (US); C07K2317/21 (EP,US);
C07K2317/34 (EP,US); C07K2317/56 (EP,US); C07K2317/565 (US);
C07K2317/567 (US); C07K2317/73 (EP,US); C07K2317/92 (EP,US) (-)
C-Set:
A61K38/15, A61K2300/00 (US,EP);
A61K39/39558, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/25]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:THERAPEUTISCHE PEPTIDE[2020/25]
English:THERAPEUTIC PEPTIDES[2020/25]
French:PEPTIDES THÉRAPEUTIQUES[2020/25]
Examination procedure18.12.2020Application deemed to be withdrawn, date of legal effect  [2021/25]
09.02.2021Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2021/25]
Parent application(s)   TooltipEP14720000.0  / EP2970908
Fees paidRenewal fee
06.11.2019Renewal fee patent year 03
06.11.2019Renewal fee patent year 04
06.11.2019Renewal fee patent year 05
06.11.2019Renewal fee patent year 06
29.06.2020Renewal fee patent year 07
Penalty fee
Additional fee for renewal fee
31.03.202108   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]WO2013049517  (DANA FARBER CANCER INST INC [US]);
by applicantEP0154316
 WO8807054
 WO8807089
 EP0401384
 US5122464
 US5225539
 WO9429351
 US5530101
 WO9632478
 US5585089
 US5591639
 US5624821
 US5648260
 US5658759
 WO9734631
 US5677425
 US5693762
 US5714350
 US5869046
 WO9951642
 WO9954342
 US5981216
 WO0042072
 US6121022
 US6165745
 US6180370
 US6194551
 WO0158957
 US6277375
 WO0206919
 EP1176195
 US6350861
 US2003022450
 WO03035835
 US2003153043
 WO03074679
 WO2004016750
 US2004067503
 WO2004029207
 WO2004035752
 US6737056
 WO2004063351
 WO2004074455
 WO2004099249
 WO2005008957
 WO2005040217
 WO2005070963
 WO2005092925
 WO2006020114
 US7317091
 US2010261269
 US8101720
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.